API Intermediate
-
(R)-5-chloro-2-(5-Methyl-1,4-diazepan-1-yl)benzo[d]oxazole
(中文) Merck’s Sleep Drug Suvorexant (Trade Name:Belsomra) was approved on August 13, 2014 by the U.S. Food and Drug Administration (FDA) to treat insomnia.
-
5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
(中文)
Product Name 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid CAS Number 956317-36-5 Appearance White solid Assay 99～102% Packing 5g;10g;25g;50g;100g;1kg Usage Suvorexant -
Suvorexant
